WHO grade, proliferation index, and progesterone receptor expression are different according to the location of meningioma
Autor: | Maiuri F., Mariniello G., Guadagno E., BARBATO, MICHELE, Corvino S., Del Basso De Caro M., GUADAGNO, ELIA |
---|---|
Přispěvatelé: | Maiuri, F., Mariniello, G., Guadagno, E., Barbato, Michele, Corvino, S., Del Basso De Caro, M., Guadagno, Elia |
Rok vydání: | 2019 |
Předmět: |
Adult
Male medicine.medical_specialty Pathology Proliferation index Skull Base Neoplasms 030218 nuclear medicine & medical imaging Meningioma 03 medical and health sciences 0302 clinical medicine Progesterone receptor otorhinolaryngologic diseases Transitional Meningioma Meningeal Neoplasms Mitotic Index Medicine Humans Spinal canal Base (exponentiation) Meningioma location Aged Cell Proliferation Skull Base business.industry Middle Aged medicine.disease Skull medicine.anatomical_structure Surgery Female Neurology (clinical) Neurosurgery Progesterone receptor expression Neoplasm Grading business Receptors Progesterone WHO grade 030217 neurology & neurosurgery |
Zdroj: | Acta neurochirurgica. 161(12) |
ISSN: | 0942-0940 |
Popis: | Meningiomas may show a different WHO grade and variable biological and clinical behaviors. The aim of the present study is to assess whether WHO grade, proliferation index, progesterone receptor (PR) expression, histological subtype, neuroradiological features, and the recurrence rate differ depending on the tumor location. Three hundred meningiomas operated on from 2006 to 2016 were reviewed. The WHO grade (2007 classification), Ki67-MIB1, progesterone receptor expression, and histological subtype were reexamined and correlated to the meningioma location, classified as medial skull base, lateral skull base, non-skull base, and spinal. Non-skull base and lateral skull base meningiomas showed significantly higher rates of atypical WHO II forms (34% and 25.5% respectively) than medial skull base (12.5%) and spinal ones (7%) (p = 0.0003) and also higher rates of tumors with Ki67-Li > 4% (42% and 38% vs 22% and 14%) (p = 0.0031). The rate of meningiomas with PR expression ≤ 50% was significantly lower in medial skull base (25%) than in non-skull base (48%) (p = 0.009). Meningothelial and transitional meningiomas were more frequent at the skull base (68.5% and 54.5%, respectively), the fibroblastic subtype at the non-skull base (48.5%), and the psammomatous at the spinal canal (50%) (p < 0.00001). Medial skull base and spinal meningiomas showed significantly lower size (p < 0.00001), lower rates of cases with lost arachnoid interface (p = 0.0022), and significantly lower recurrence rates (p = 0.0035) than lateral skull base and non-skull base meningiomas. Medial skull base meningiomas show lower size, lower rate of atypical forms, lower Ki67-Li values, and significantly higher PR expression than those at the lateral skull base and non-skull base. This corresponds to lesser aggressiveness and lower recurrence rates. |
Databáze: | OpenAIRE |
Externí odkaz: |